The Role of D-Dimer for Optimal Thromboprophylaxis Strategy in Patients with COVID-19

Background: Novel coronavirus infection (SARS CoV-2 or COVID-19) is associated with a high risk of thrombotic complications, including macro- and micro-thrombi in major organs, leading to increased morbidity and mortality. Anticoagulant use, mainly heparin, which has both anticoagulant and anti-infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhoopat, Lantarima, Martynova, Anastasia, Choi, April, Pattharanitima, Pattharawin, Han, Semi, Du, Senxi, Syed, Ibrahim, Chan, Catherine, O'Neill, Caitlin, Oh, Esther, O'Connell, Casey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
332.Anticoagulation and Antithrombotic Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330322/
http://dx.doi.org/10.1182/blood-2020-141732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330322/
http://dx.doi.org/10.1182/blood-2020-141732

Ejemplares similares